Enterotoxigenic Escherichia Coli (ETEC) ETVAX Vaccine Trial in Bangladesh

Clinical trial NCT02531802 · COMPLETED

Trial details

NCT number: NCT02531802
Sponsor: PATH
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Escherichia Coli Diarrhea

Start date: 2015-10-01
Primary completion: 2017-07-29
Enrollment: 475

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.